Cargando…
Emerging issues in radiogenic cataracts and cardiovascular disease
In 2011, the International Commission on Radiological Protection issued a statement on tissue reactions (formerly termed non-stochastic or deterministic effects) to recommend lowering the threshold for cataracts and the occupational equivalent dose limit for the crystalline lens of the eye. Furtherm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202294/ https://www.ncbi.nlm.nih.gov/pubmed/24824673 http://dx.doi.org/10.1093/jrr/rru036 |
_version_ | 1782340291011805184 |
---|---|
author | Hamada, Nobuyuki Fujimichi, Yuki Iwasaki, Toshiyasu Fujii, Noriko Furuhashi, Masato Kubo, Eri Minamino, Tohru Nomura, Takaharu Sato, Hitoshi |
author_facet | Hamada, Nobuyuki Fujimichi, Yuki Iwasaki, Toshiyasu Fujii, Noriko Furuhashi, Masato Kubo, Eri Minamino, Tohru Nomura, Takaharu Sato, Hitoshi |
author_sort | Hamada, Nobuyuki |
collection | PubMed |
description | In 2011, the International Commission on Radiological Protection issued a statement on tissue reactions (formerly termed non-stochastic or deterministic effects) to recommend lowering the threshold for cataracts and the occupational equivalent dose limit for the crystalline lens of the eye. Furthermore, this statement was the first to list circulatory disease (cardiovascular and cerebrovascular disease) as a health hazard of radiation exposure and to assign its threshold for the heart and brain. These changes have stimulated various discussions and may have impacts on some radiation workers, such as those in the medical sector. This paper considers emerging issues associated with cataracts and cardiovascular disease. For cataracts, topics dealt with herein include (i) the progressive nature, stochastic nature, target cells and trigger events of lens opacification, (ii) roles of lens protein denaturation, oxidative stress, calcium ions, tumor suppressors and DNA repair factors in cataractogenesis, (iii) dose rate effect, radiation weighting factor, and classification systems for cataracts, and (iv) estimation of the lens dose in clinical settings. Topics for cardiovascular disease include experimental animal models, relevant surrogate markers, latency period, target tissues, and roles of inflammation and cellular senescence. Future research needs are also discussed. |
format | Online Article Text |
id | pubmed-4202294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42022942014-10-23 Emerging issues in radiogenic cataracts and cardiovascular disease Hamada, Nobuyuki Fujimichi, Yuki Iwasaki, Toshiyasu Fujii, Noriko Furuhashi, Masato Kubo, Eri Minamino, Tohru Nomura, Takaharu Sato, Hitoshi J Radiat Res Review In 2011, the International Commission on Radiological Protection issued a statement on tissue reactions (formerly termed non-stochastic or deterministic effects) to recommend lowering the threshold for cataracts and the occupational equivalent dose limit for the crystalline lens of the eye. Furthermore, this statement was the first to list circulatory disease (cardiovascular and cerebrovascular disease) as a health hazard of radiation exposure and to assign its threshold for the heart and brain. These changes have stimulated various discussions and may have impacts on some radiation workers, such as those in the medical sector. This paper considers emerging issues associated with cataracts and cardiovascular disease. For cataracts, topics dealt with herein include (i) the progressive nature, stochastic nature, target cells and trigger events of lens opacification, (ii) roles of lens protein denaturation, oxidative stress, calcium ions, tumor suppressors and DNA repair factors in cataractogenesis, (iii) dose rate effect, radiation weighting factor, and classification systems for cataracts, and (iv) estimation of the lens dose in clinical settings. Topics for cardiovascular disease include experimental animal models, relevant surrogate markers, latency period, target tissues, and roles of inflammation and cellular senescence. Future research needs are also discussed. Oxford University Press 2014-09 2014-05-13 /pmc/articles/PMC4202294/ /pubmed/24824673 http://dx.doi.org/10.1093/jrr/rru036 Text en © The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Review Hamada, Nobuyuki Fujimichi, Yuki Iwasaki, Toshiyasu Fujii, Noriko Furuhashi, Masato Kubo, Eri Minamino, Tohru Nomura, Takaharu Sato, Hitoshi Emerging issues in radiogenic cataracts and cardiovascular disease |
title | Emerging issues in radiogenic cataracts and cardiovascular disease |
title_full | Emerging issues in radiogenic cataracts and cardiovascular disease |
title_fullStr | Emerging issues in radiogenic cataracts and cardiovascular disease |
title_full_unstemmed | Emerging issues in radiogenic cataracts and cardiovascular disease |
title_short | Emerging issues in radiogenic cataracts and cardiovascular disease |
title_sort | emerging issues in radiogenic cataracts and cardiovascular disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202294/ https://www.ncbi.nlm.nih.gov/pubmed/24824673 http://dx.doi.org/10.1093/jrr/rru036 |
work_keys_str_mv | AT hamadanobuyuki emergingissuesinradiogeniccataractsandcardiovasculardisease AT fujimichiyuki emergingissuesinradiogeniccataractsandcardiovasculardisease AT iwasakitoshiyasu emergingissuesinradiogeniccataractsandcardiovasculardisease AT fujiinoriko emergingissuesinradiogeniccataractsandcardiovasculardisease AT furuhashimasato emergingissuesinradiogeniccataractsandcardiovasculardisease AT kuboeri emergingissuesinradiogeniccataractsandcardiovasculardisease AT minaminotohru emergingissuesinradiogeniccataractsandcardiovasculardisease AT nomuratakaharu emergingissuesinradiogeniccataractsandcardiovasculardisease AT satohitoshi emergingissuesinradiogeniccataractsandcardiovasculardisease |